医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Cabot Corporation Receives Responsible Care® Certification in Xingtai, China

2018年12月17日 PM11:00
このエントリーをはてなブックマークに追加


 

BOSTON

Cabot Corporation (NYSE: CBT) today announced that its carbon black manufacturing facility in Xingtai, China has been officially certified to the Responsible Care® 14001 standard, the globally recognized gold standard for safety & health, environmental and security management systems established by the American Chemistry Council’s (ACC) Responsible Care® program. Through RC14001® certification, the ACC promotes superior performance and transparency throughout the global chemical industry by ensuring its members continuously improve internal programs that have a positive impact on commercial partners, employee and contractor safety and health, communities, security and the environment.

This is the second Cabot manufacturing site in China to receive this certification this year. In March 2018, Cabot celebrated the certification of its Tianjin facility, becoming the first chemical company in China to be certified by auditors from the international registrar, BSI, in accordance with the stringent international standards of the Responsible Care Management System® program.

This accomplishment is consistent with Cabot’s ongoing global commitment to the Responsible Care principles and the highest level of transparent performance. This recognition supplements the site’s well-established safety, health & environmental management program, which also includes ISO 14001 and OSHAS 18001 certifications.

“We are proud of this latest certification, as recognition for our commitment to operate all of our sites with the highest regard for the safety of our employees and the environment,” said Jeff Zhu, president, Asia Pacific region. “We are excited to reach yet another important milestone and look forward to completing certification at our remaining China sites.”

The Responsible Care program is a global voluntary initiative under which the chemical industry works to continuously improve and achieve excellence in safety and health, security and environmental performance. The standard promotes accountability and communication with stakeholders about products and processes and requires companies to adopt best practices in the manufacturing and supply of safe and affordable goods that bring real benefits to society. The RC14001 certification represents a robust technical standard that combines the attributes of the Responsible Care Management System program and the ISO 14001 environmental standard to achieve higher standards of performance.

“We believe it is important to act as a responsible corporate citizen in all of the communities in which we operate,” explained Martin O’Neill, senior vice president, Safety, Health and Environment. “We are committed to acting in accordance with the principles of Responsible Care® on a global scale, and thank the Xingtai team, and our employees around the world, for their commitment to safety, health and environmental best practices.”

For more information on Cabot’s commitment to safety, health and environmental excellence, visit cabotcorp.com/responsibility.

About Cabot Corporation
Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company, headquartered in Boston, Massachusetts. The company is a leading provider of rubber and specialty carbonsactivated carboninkjet colorantscesium formate drilling fluidsmasterbatches and conductive compoundsfumed silica and aerogel. For more information on Cabot, please visit the company’s website at: http://www.cabotcorp.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181217005361/en/

CONTACT

Erin Caron
617-342-6257
erin.caron@cabotcorp.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Seoul Viosys’ Violeds Modules Proven to Disinfect 99% of Airborne Viruses in a Recent Testing Result
  • Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan
  • Kaye推出适用于冷链运输市场的Kaye® Log -80℃ 疫苗温度记录器,以满足COVID-19疫苗储存和运输的要求
  • Kaye® (ケイ)は、COVID-19ワクチンの輸送・保管のニーズに応えるためにKaye® ログ -80ワクチン温度ロガーを、コールドチェーン市場向けに導入(発売)します。
  • DNP的新型非接触式透明屏幕可通过手的动作进行操作